x
Filter:
Filters applied
- Oncology
- Carter, H BallentineRemove Carter, H Ballentine filter
- 2017 - 2022Remove 2017 - 2022 filter
Oncology
2 Results
- Oncology
Evaluation of Apparent Diffusion Coefficient as a Predictor of Grade Reclassification in Men on Active Surveillance for Prostate Cancer
UrologyVol. 138p84–90Published online: January 15, 2020- Mitchell M. Huang
- Katarzyna J. Macura
- Patricia Landis
- Jonathan I. Epstein
- Rakhee Gawande
- H. Ballentine Carter
- and others
Cited in Scopus: 1To evaluate the association between apparent diffusion coefficient (ADC) on initial multiparametric MRI (mpMRI) and biopsy grade reclassification (GR) to grade group (GG) ≥2 prostate cancer (CaP) in men on active surveillance (AS) with GG 1 CaP. - Oncology
Clinical Evaluation of an Individualized Risk Prediction Tool for Men on Active Surveillance for Prostate Cancer
UrologyVol. 121p118–124Published online: August 29, 2018- Joseph H. Huntley
- Rebecca Y. Coley
- H. Ballentine Carter
- Archana Radhakrishnan
- Melinda Krakow
- Craig E. Pollack
Cited in Scopus: 5To determine whether providing individualized predictions of health outcomes to men on active surveillance (AS) alleviates cancer-related anxiety and improves risk understanding.